Literature DB >> 1445283

Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Relationship to adenylate cyclase inhibition.

M B Anand-Srivastava1.   

Abstract

We have previously shown that the stimulatory effects of guanine nucleotides, N-ethylcarboxamide-adenosine and other agonists on adenylate cyclase activity were diminished in aorta and heart sarcolemma of spontaneously hypertensive rats (SHR) [Anand-Srivastava (1988) Biochem. Pharmacol. 37, 3017-3022]. In the present studies, we have examined whether the decreased response of these agonists is due to the defective GTP-binding proteins (G-proteins) which couple the receptors to adenylate cyclase, and have therefore measured the levels of G-proteins in aorta and heart from SHR and their respective Wistar-Kyoto (WKY) controls by using pertussis toxin (PT)- and cholera toxin (CT)-catalysed ADP-ribosylations and immunoblotting techniques using specific antibodies against G-proteins. The labelling with [32P]NAD+ and PT identified a 40/41 kDa protein in heart and aorta from WKY and SHR and was significantly increased in the hearts (approximately 100%) and aorta (approximately 30-40%), from SHR as compared with WKY. Immunoblotting revealed an increase in the levels of the G-protein alpha-subunits Gi alpha-2 and Gi alpha-3 in heart and Gi alpha-2 in aorta, whereas no change in Go alpha was observed in heart from SHR and WKY. On the other hand, no differences were observed in CT labelling or immunoblotting of stimulatory G-protein (Gs) in heart and aorta from WKY and SHR. In addition, CT stimulated the adenylate cyclase activity in heart sarcolemma from WKY and SHR to a similar extent. These results were correlated with adenylate cyclase inhibition and stimulation by various hormones. Angiotensin II (AII), atrial natriuretic factor (ANF) and oxotremorine-mediated inhibition was found to be greater in SHR as compared with WKY, whereas the stimulatory effects of adrenaline, isoprenaline, dopamine and forskolin were diminished in SHR aorta as compared to WKY. These results indicate that regulatory protein G(i) is more expressed in SHR, which may be associated with the decreased responsiveness of stimulatory hormones and increased sensitivity of inhibitory hormones to stimulate/inhibit adenylate cyclase activity. It may thus be suggested that the enhanced G(i) activity may be one of the mechanisms responsible for the diminished vascular tone and impaired myocardial functions in hypertension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445283      PMCID: PMC1132082          DOI: 10.1042/bj2880079

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.

Authors:  D M Gill; R Meren
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system.

Authors:  D Cassel; T Pfeuffer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

4.  Fat cell adenylate cyclase and beta-adrenergic receptors in altered thyroid states.

Authors:  C C Malbon; F J Moreno; R J Cabelli; J N Fain
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

5.  Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein.

Authors:  T Katada; M Ui
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

6.  Alterations in myocardial adenylate cyclase in spontaneously hypertensive rats.

Authors:  G C Palmer; S Greenberg
Journal:  Pharmacology       Date:  1979       Impact factor: 2.547

7.  Ontogenetic development of isoproterenol subsensitivity of myocardial adenylate cyclase and beta-adrenergic receptors in spontaneously hypertensive rats.

Authors:  R C Bhalla; R V Sharma; S Ramanathan
Journal:  Biochim Biophys Acta       Date:  1980-11-03

8.  Atrial natriuretic factor inhibits adenylate cyclase activity.

Authors:  M B Anand-Srivastava; D J Franks; M Cantin; J Genest
Journal:  Biochem Biophys Res Commun       Date:  1984-06-29       Impact factor: 3.575

9.  Angiotensin II receptors negatively coupled to adenylate cyclase in rat aorta.

Authors:  M B Anand-Srivastava
Journal:  Biochem Biophys Res Commun       Date:  1983-12-16       Impact factor: 3.575

10.  Guanine nucleotide inhibition of cyc- S49 mouse lymphoma cell membrane adenylyl cyclase.

Authors:  J D Hildebrandt; J Hanoune; L Birnbaumer
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

View more
  20 in total

1.  Inhibition of atrial natriuretic peptide (ANP) C receptor expression by antisense oligodeoxynucleotides in A10 vascular smooth-muscle cells is associated with attenuation of ANP-C-receptor-mediated inhibition of adenylyl cyclase.

Authors:  A Palaparti; Y Li; M B Anand-Srivastava
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

2.  Streptozotocin-induced diabetes impairs G-protein linked signal transduction in vascular smooth muscle.

Authors:  Shehla Hashim; Yi Yong Liu; Rui Wang; Madhu B Anand-Srivastava
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

3.  Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats.

Authors:  S J Vyas; C M Blaschak; M R Chinoy; E K Jackson
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

4.  Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy.

Authors:  M B Anand-Srivastava; J H McNeill; X P Yang
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Prolonged atrial natriuretic peptide exposure stimulates guanylyl cyclase-a degradation.

Authors:  Darcy R Flora; Lincoln R Potter
Journal:  Endocrinology       Date:  2010-04-09       Impact factor: 4.736

6.  Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular cardiomyocytes.

Authors:  M A Bogoyevitch; A Clerk; P H Sugden
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

7.  Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.

Authors:  H Yoshida; M Takahashi; K Tanonaka; T Maki; Y Nasa; S Takeo
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

8.  Repeated cell transplantation and adjunct renal denervation in ischemic heart failure: exploring modalities for improving cell therapy efficacy.

Authors:  David J Polhemus; Rishi K Trivedi; Thomas E Sharp; Zhen Li; Traci T Goodchild; Amy Scarborough; Geoffrey de Couto; Eduardo Marbán; David J Lefer
Journal:  Basic Res Cardiol       Date:  2019-01-17       Impact factor: 17.165

9.  Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

Authors:  Sándor Bátkai; Pál Pacher; Douglas Osei-Hyiaman; Svetlana Radaeva; Jie Liu; Judith Harvey-White; László Offertáler; Ken Mackie; M Audrey Rudd; Richard D Bukoski; George Kunos
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

10.  Defective ANF-R2/ANP-C receptor-mediated signalling in hypertension.

Authors:  J Marcil; M B Anand-Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.